Terapias dirigidas en combinación con hormonoterapia en cáncer de mama avanzado HER2- negativo - page 18



The incidence of grade ≥2 stomatitis at 8 weeks was 2.4% (n=2,

95%CI 0.29-8.24,

<0.001) compared with total of 33% in BOLERO-2

Incidence of Stomatitis

BOLERO-2, The Breast Cancer Trials of Oral Everolimus-2

BOLER-2 stomatitis grading based on CTCAE v3.0

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,8,9,10,11,12,13,14,15,16,17 19,20,21,22,23,24,25,26,27,28,...45